Quality of medicines questions and answers: Part 1

Human medicines European public assessment report (EPAR): Vpriv, velaglucerase alfa, Date of authorisation: 26/08/2010, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR): Jaypirca, pirtobrutinib, Date of authorisation: 30/10/2023, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Tadalafil Lilly, tadalafil, Date of authorisation: 22/03/2017, Revision: 8, Status: Authorised

List of medicinal products under additional monitoring

List of medicinal products under additional monitoring

List of medicines under additional monitoring

Human medicines European public assessment report (EPAR): Cialis, tadalafil, Date of authorisation: 12/11/2002, Revision: 34, Status: Authorised

Human medicines European public assessment report (EPAR): Omvoh, mirikizumab, Date of authorisation: 26/05/2023, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Forsteo, teriparatide, Date of authorisation: 10/06/2003, Revision: 25, Status: Authorised